annual cash & cash equivalents:
$987.23M+$491.92M(+99.31%)Summary
- As of today (September 12, 2025), RPRX annual cash & cash equivalents is $987.23 million, with the most recent change of +$491.92 million (+99.31%) on December 31, 2024.
- During the last 3 years, RPRX annual cash & cash equivalents has fallen by -$1.20 billion (-54.90%).
- RPRX annual cash & cash equivalents is now -54.90% below its all-time high of $2.19 billion, reached on December 31, 2021.
Performance
RPRX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$645.11M-$454.71M(-41.34%)Summary
- As of today (September 12, 2025), RPRX quarterly cash & cash equivalents is $645.11 million, with the most recent change of -$454.71 million (-41.34%) on June 30, 2025.
- Over the past year, RPRX quarterly cash & cash equivalents has dropped by -$1.16 billion (-64.22%).
- RPRX quarterly cash & cash equivalents is now -77.09% below its all-time high of $2.82 billion, reached on June 30, 2020.
Performance
RPRX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RPRX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.3% | -64.2% |
| 3 y3 years | -54.9% | -76.6% |
| 5 y5 years | +189.8% | -77.1% |
RPRX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.9% | +99.3% | -76.6% | +30.2% |
| 5 y | 5-year | -54.9% | +189.8% | -77.1% | +30.2% |
| alltime | all time | -54.9% | +189.8% | -77.1% | +89.4% |
RPRX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $645.11M(-41.3%) |
| Mar 2025 | - | $1.10B(+11.4%) |
| Dec 2024 | $987.23M(+99.3%) | $987.23M(-1.1%) |
| Sep 2024 | - | $998.55M(-44.6%) |
| Jun 2024 | - | $1.80B(+106.8%) |
| Mar 2024 | - | $872.00M(+76.1%) |
| Dec 2023 | $495.31M(-71.5%) | $495.31M(-47.4%) |
| Sep 2023 | - | $941.75M(-56.8%) |
| Jun 2023 | - | $2.18B(+10.1%) |
| Mar 2023 | - | $1.98B(+13.9%) |
| Dec 2022 | $1.74B | $1.74B(+12.7%) |
| Sep 2022 | - | $1.54B(-44.2%) |
| Jun 2022 | - | $2.76B(+18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.34B(+6.9%) |
| Dec 2021 | $2.19B(+6.2%) | $2.19B(+3.6%) |
| Sep 2021 | - | $2.11B(+2.9%) |
| Jun 2021 | - | $2.05B(+11.2%) |
| Mar 2021 | - | $1.85B(-10.4%) |
| Dec 2020 | $2.06B(+505.3%) | $2.06B(-5.2%) |
| Sep 2020 | - | $2.18B(-22.7%) |
| Jun 2020 | - | $2.82B(+133.4%) |
| Mar 2020 | - | $1.21B(+254.1%) |
| Dec 2019 | $340.65M(-82.3%) | $340.65M |
| Dec 2018 | $1.92B(+39.3%) | - |
| Dec 2017 | $1.38B(-17.5%) | - |
| Dec 2016 | $1.67B(-2.7%) | - |
| Dec 2015 | $1.72B | - |
FAQ
- What is Royalty Pharma plc annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Royalty Pharma plc?
- What is Royalty Pharma plc annual cash & cash equivalents year-on-year change?
- What is Royalty Pharma plc quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly cash & cash equivalents year-on-year change?
What is Royalty Pharma plc annual cash & cash equivalents?
The current annual cash & cash equivalents of RPRX is $987.23M
What is the all time high annual cash & cash equivalents for Royalty Pharma plc?
Royalty Pharma plc all-time high annual cash & cash equivalents is $2.19B
What is Royalty Pharma plc annual cash & cash equivalents year-on-year change?
Over the past year, RPRX annual cash & cash equivalents has changed by +$491.92M (+99.31%)
What is Royalty Pharma plc quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RPRX is $645.11M
What is the all time high quarterly cash & cash equivalents for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly cash & cash equivalents is $2.82B
What is Royalty Pharma plc quarterly cash & cash equivalents year-on-year change?
Over the past year, RPRX quarterly cash & cash equivalents has changed by -$1.16B (-64.22%)